Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin; Faith B. Davis; Paul  J. Davis; Shaker A. Mousa

Combination treatment of cancer with cetuximab and tetrac

Hung-Yun Lin (Inventor), Faith B. Davis (Inventor), Paul J. Davis (Inventor), Shaker A. Mousa (Inventor)

TMU Research Center of Cancer Translational Medicine

Research output: Patent

Abstract

Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

Original language	English
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://patents.google.com/patent/US9180107B2/en

Cite this

@misc{40c88d1231914ee2b4b8c54bc016f246,

title = "Combination treatment of cancer with cetuximab and tetrac",

abstract = "Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.",

author = "Hung-Yun Lin and {B. Davis}, Faith and {J. Davis}, Paul and {A. Mousa}, Shaker",

year = "2010",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Combination treatment of cancer with cetuximab and tetrac

AU - Lin, Hung-Yun

AU - B. Davis, Faith

AU - J. Davis, Paul

AU - A. Mousa, Shaker

PY - 2010

Y1 - 2010

N2 - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

AB - Provided herein are compositions and methods for treating cancer by increasing the inhibitory effect of cetuximab on HIF1α expression by administering cetuximab in combination with anti-angiogenic thyroid hormone analogs such as tetrac or triac.

M3 - Patent

ER -

Combination treatment of cancer with cetuximab and tetrac

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this